EDEM1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.045200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.928800E-01
Normal-vs-Stage2
5.379200E-01
Normal-vs-Stage3
2.863800E-01
Normal-vs-Stage4
5.855800E-01
Stage1-vs-Stage2
3.136000E-01
Stage1-vs-Stage3
1.809370E-01
Stage1-vs-Stage4
1.518800E-01
Stage2-vs-Stage3
3.275200E-03
Stage2-vs-Stage4
8.524800E-01
Stage3-vs-Stage4
1.600050E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.057200E-01
Normal-vs-AfricanAmerican
4.593400E-01
Normal-vs-Asian
1.189790E-01
Caucasian-vs-AfricanAmerican
6.673800E-01
Caucasian-vs-Asian
2.774000E-01
AfricanAmerican-vs-Asian
2.972600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.966200E-01
Normal-vs-Female
5.210200E-01
Male-vs-Female
6.900200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.982400E-01
Normal-vs-Age(41-60Yrs)
6.372400E-01
Normal-vs-Age(61-80Yrs)
4.656600E-01
Normal-vs-Age(81-100Yrs)
3.940200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.961400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.643000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.871600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.657920E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.301900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.369600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.124800E-01
Normal-vs-Daily Drinker
4.038000E-01
Normal-vs-Weekly Drinker
1.599640E-01
Normal-vs-Occasional Drinker
4.001600E-01
Normal-vs-Social Drinker
3.063400E-01
Non Drinker-vs-Daily Drinker
4.778600E-01
Non Drinker-vs-Weekly Drinker
9.331800E-01
Non Drinker-vs-Occasional Drinker
3.093600E-01
Non Drinker-vs-Social Drinker
5.528000E-01
Daily Drinker-vs-Weekly Drinker
5.493800E-01
Daily Drinker-vs-Occasional Drinker
6.304500E-02
Daily Drinker-vs-Social Drinker
1.620390E-01
Weekly Drinker-vs-Occasional Drinker
2.754400E-01
Weekly Drinker-vs-Social Drinker
4.811200E-01
Occasional Drinker-vs-Social Drinker
7.005400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.184000E-01
Normal-vs-Grade 2
8.120200E-02
Normal-vs-Grade 3
1.421380E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.415240E-01
Grade 1-vs-Grade 3
4.058300E-02
Grade 1-vs-Grade 4
4.184000E-01
Grade 2-vs-Grade 3
2.435000E-01
Grade 2-vs-Grade 4
8.120200E-02
Grade 3-vs-Grade 4
1.421380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.005000E-01
Normal-vs-NonDiabetic
4.568400E-01
Diabetic-vs-NonDiabetic
3.618600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.826600E-01
Normal-vs-NoPancreatitis
1.138380E-01
Pancreatitis-vs-NoPancreatitis
9.424800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.728960E-01
Normal-vs-N1
5.110400E-01
N0-vs-N1
9.933400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.998000E-01
Normal-vs-TP53-NonMutant
1.117820E-01
TP53-Mutant-vs-TP53-NonMutant
2.885800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
